Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
| Revenue (TTM) | $274.19M |
| Gross Profit (TTM) | $97.71M |
| EBITDA | $3.05M |
| Operating Margin | -16.40% |
| Return on Equity | -5.93% |
| Return on Assets | -1.67% |
| Revenue/Share (TTM) | $2.04 |
| Book Value | $2.03 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | 0.54 |
| EV/Revenue | 0.776 |
| EV/EBITDA | 37.77 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -8.90% |
| Shares Outstanding | $140.78M |
| Float | $98.21M |
| % Insiders | 30.26% |
| % Institutions | 6.71% |
Volatility is currently contracting